Cytokines as Biomarkers of Treatment Response to IFNβ in Relapsing-Remitting Multiple Sclerosis

Background. MS patients show a remarkable heterogeneity in their response to disease modifying treatments. Given the need for early treatment initiation and the diversity of available options, a predictive marker that indicates good or poor response to treatment is highly desirable. Objective. To fi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Dimisianos, Nikolaos, Rodi, Maria, Kalavrizioti, Dimitra, Georgiou, Vasileios, Papathanasopoulos, Panagiotis, Mouzaki, Athanasia
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Hindawi Publishing Corporation 2014
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4134814/
https://ncbi.nlm.nih.gov/pubmed/25152817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/436764
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items